ImmunoBrain announced that Phase 1b data for IBC-
Browsing: All news
Category Added in a WPeMatico Campaign
ProMIS presented data at the Alzheimer’s Associ
New analyses suggest Alzheon’s therapy may pro
The startup is betting that the future of longev
Eisai and Biogen presented data at the Alzheimer’s Association International Conference 2026 in London showing that a lecanemab subcutaneous autoinjector (LEQEMBI) produced exposure, efficacy and safety comparable to the approved intravenous initiation regimen in people with early Alzheimer’s disease. According…
Cognito Therapeutics presented exploratory cerebr
At the Alzheimer’s Association International Co
NeuroTherapia will present data from its recently
Indiana University and PharmatrophiX presented a
Aeon welcomed the establishment of the Dubai Long